Voloridge Investment Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-230,410
| Closed | -$9.28M | – | 1362 |
|
2024
Q2 | $9.28M | Sell |
230,410
-291,222
| -56% | -$11.7M | 0.03% | 581 |
|
2024
Q1 | $18.5M | Sell |
521,632
-430,930
| -45% | -$15.3M | 0.07% | 351 |
|
2023
Q4 | $28.2M | Sell |
952,562
-95,401
| -9% | -$2.82M | 0.11% | 242 |
|
2023
Q3 | $21.8M | Buy |
1,047,963
+170,932
| +19% | +$3.55M | 0.11% | 268 |
|
2023
Q2 | $21.5M | Buy |
877,031
+392,407
| +81% | +$9.63M | 0.1% | 268 |
|
2023
Q1 | $19.7M | Buy |
484,624
+434,770
| +872% | +$17.7M | 0.1% | 287 |
|
2022
Q4 | $2.24M | Sell |
49,854
-31,905
| -39% | -$1.43M | 0.01% | 930 |
|
2022
Q3 | $3.91M | Buy |
81,759
+20,506
| +33% | +$981K | 0.02% | 736 |
|
2022
Q2 | $3.63M | Buy |
+61,253
| New | +$3.63M | 0.02% | 794 |
|
2022
Q1 | – | Sell |
-21,839
| Closed | -$3.29M | – | 1701 |
|
2021
Q4 | $3.29M | Buy |
+21,839
| New | +$3.29M | 0.02% | 882 |
|
2021
Q2 | – | Sell |
-31,491
| Closed | -$2.78M | – | 1786 |
|
2021
Q1 | $2.78M | Buy |
+31,491
| New | +$2.78M | 0.02% | 697 |
|
2019
Q2 | – | Sell |
-21,349
| Closed | -$1.36M | – | 1066 |
|
2019
Q1 | $1.36M | Buy |
+21,349
| New | +$1.36M | 0.04% | 382 |
|